scholarly journals Central venous catheter infection associated with Pseudozyma aphidis in a child with short gut syndrome

2008 ◽  
Vol 57 (4) ◽  
pp. 516-518 ◽  
Author(s):  
Shau-Shau Lin ◽  
Thomas Pranikoff ◽  
Shani F. Smith ◽  
Mary E. Brandt ◽  
Kemery Gilbert ◽  
...  
Keyword(s):  
Central Venous Catheter ◽  
Venous Catheter ◽  
Successful Outcome ◽  
Smut Fungi ◽  
Central Venous ◽  
Short Gut Syndrome ◽  
Paediatric Case ◽  
Pseudozyma Aphidis ◽  
Central Venous Catheter Infection ◽  
Anti Fungal

Pseudozyma aphidis is a heterobasidiomycetous yeast related to the smut fungi in the genus Ustilago. Pseudozyma species are usually isolated from plants and rarely from clinical specimens. We report what is believed to be the first paediatric case of central venous catheter (CVC)-related fungaemia associated with P. aphidis. Prompt removal of the CVC in conjunction with anti-fungal therapy resulted in a successful outcome.

CE Article: Central Venous Catheter Infection in Canadian Home Parenteral Nutrition Patients: A 5-Year Multicenter Retrospective Study

2020 ◽  
Vol 25 (1) ◽  
pp. 16-26
Author(s):  
Olivia Saqui ◽  
G. Fernandes ◽  
J. Allard
Keyword(s):  
Health Care ◽  
Retrospective Study ◽  
Patient Education ◽  
Central Venous Catheter ◽  
Parenteral Nutrition ◽  
Venous Catheter ◽  
Infection Rates ◽  
Central Venous ◽  
Central Venous Catheter Infection ◽  
Significant Health

Highlights A lower CVC infection rate suggests an improvement in practice and education. CVC infection remains a complication that often requires significant health care resources. Use of tunneled CVC and patient education on catheter care reduces CVC infection rates.

scholarly journals Linezolid lock prophylaxis of central venous catheter infection

2008 ◽  
Vol 57 (4) ◽  
pp. 534-535 ◽  
Author(s):  
Jérôme Patrick Fennell ◽  
Martin O'Donohoe ◽  
Martin Cormican ◽  
Maureen Lynch
Keyword(s):  
Central Venous Catheter ◽  
Hospital Admissions ◽  
Blood Stream Infection ◽  
Central Venous Access ◽  
Venous Catheter ◽  
Venous Access ◽  
Blood Stream ◽  
Central Venous ◽  
Central Venous Catheter Infection ◽  
The Impact

Central venous catheter (CVC)-related infections are a major problem for patients requiring long-term venous access and may result in frequent hospital admissions and difficulties in maintaining central venous access. CVC-related blood stream infections are associated with increased duration of inpatient stay and cost approximately \#8364;13 585 per patient [Blot, S. I., Depuydt, P., Annemans, L., Benoit, D., Hoste, E., De Waele, J. J., Decruyenaere, J., Vogelaers, D., Colardyn, F. & Vandewoude, K. H. (2005). Clin Infect Dis 41, 1591–1598]. Antimicrobial lock therapy may prevent CVC-related blood stream infection, preserve central venous access and reduce hospital admissions. In this paper, the impact of linezolid lock prophylaxis in a patient with short bowel syndrome is described.

Strategies to Prevent Central Venous Catheter Infection

2000 ◽  
Vol Volume 17 (Number 02) ◽  
pp. 139-146
Author(s):  
Gunnar B. Lund ◽  
Sanjay Misra ◽  
Sharon Kirkwood
Keyword(s):  
Central Venous Catheter ◽  
Venous Catheter ◽  
Central Venous ◽  
Catheter Infection ◽  
Central Venous Catheter Infection

scholarly journals Treatment of Central Venous Silastic Catheter Infections Using Hydrochloric Acid

1982 ◽  
Vol 10 (4) ◽  
pp. 314-318 ◽  
Author(s):  
L. I. G. Worthley
Keyword(s):  
Hydrochloric Acid ◽  
Central Venous Catheter ◽  
Venous Catheter ◽  
Central Venous ◽  
Silastic Catheter ◽  
Catheter Sepsis ◽  
Central Venous Catheter Infection ◽  
Catheter Infections ◽  
Acid Clearing

Patients receiving long-term home parenteral nutrition through a subcutaneously tunnelled central venous silastic catheter underwent a trial of 1.5 ml of 2M hydrochloric acid instilled into the catheter each time an episode of catheter sepsis was diagnosed. Four patients had eleven episodes of central venous catheter infection, with the hydrochloric acid clearing the infection on seven occasions, and unblocking the catheter once. The mainstay of therapy for catheter sepsis is removal of the catheter. However, in patients with subcutaneously tunnelled central venous silastic catheters, if reinserting the catheter is anticipated to be a major problem then a small dose of hydrochloric acid in an attempt to clear the infection may be worth a trial.

scholarly journals Conversion of Staphylococcus epidermidis Strains from Commensal to Invasive by Expression of the ica Locus Encoding Production of Biofilm Exopolysaccharide

2005 ◽  
Vol 73 (5) ◽  
pp. 3188-3191 ◽  
Author(s):  
Hualin Li ◽  
Lin Xu ◽  
Jianping Wang ◽  
Yumei Wen ◽  
Cuong Vuong ◽  
...  
Keyword(s):  
Central Venous Catheter ◽  
Staphylococcus Epidermidis ◽  
Biofilm Formation ◽  
Venous Catheter ◽  
Infection Model ◽  
Polysaccharide Intercellular Adhesin ◽  
Central Venous ◽  
Biofilm Production ◽  
Central Venous Catheter Infection

ABSTRACT To test if biofilm formation in Staphylococcus epidermidis is dependent on the polysaccharide intercellular adhesin, whose biosynthesis is driven by the ica locus, a plasmid containing the ica locus was transferred to three ica-negative strains. Using in vitro biofilm assays and a rat central venous catheter infection model, we confirmed the importance of the ica locus for biofilm production and pathogenesis of S. epidermidis.

scholarly journals In vivo development of heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA), GISA and daptomycin resistance in a patient with meticillin-resistant S. aureus endocarditis

2009 ◽  
Vol 58 (3) ◽  
pp. 376-380 ◽  
Author(s):  
Andrew Kirby ◽  
Kavya Mohandas ◽  
Caroline Broughton ◽  
Timothy J. Neal ◽  
Godfrey W. Smith ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Infective Endocarditis ◽  
Central Venous Catheter ◽  
Venous Catheter ◽  
Resistance Mechanisms ◽  
Central Venous ◽  
Glycopeptide Resistance ◽  
Mrsa Infection ◽  
Central Venous Catheter Infection

We report a patient who developed a meticillin-resistant Staphylococcus aureus (MRSA) central venous catheter infection complicated by infective endocarditis. The patient was initially treated with glycopeptides, which led to the development of heterogeneous glycopeptide resistance, the detection of which required the use of a macro Etest screening test. Subsequently, the causative strain, confirmed by PFGE as a UK epidemic MRSA-15, was treated with daptomycin, and again resistance developed in vivo. The development in vivo of resistance to both these agents suggests that the resistance mechanisms may be associated. We suggest that the clinician managing MRSA infection should anticipate daptomycin resistance when reduced glycopeptide susceptibility is detected.

Sign in / Sign up

Export Citation Format

Share Document